Cargando…
BRAF(V600E) drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
BRAF(V600E) confers poor prognosis and is associated with a distinct subtype of colorectal cancer (CRC). Little is known, however, about the genetic events driving the initiation and progression of BRAF(V600E) mutant CRCs. Recent genetic analyses of CRCs indicate that BRAF(V600E) often coexists with...
Autores principales: | Reischmann, Nadine, Andrieux, Geoffroy, Griffin, Ricarda, Reinheckel, Thomas, Boerries, Melanie, Brummer, Tilman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498370/ https://www.ncbi.nlm.nih.gov/pubmed/32792685 http://dx.doi.org/10.1038/s41388-020-01414-9 |
Ejemplares similares
-
BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?
por: Herr, Ricarda, et al.
Publicado: (2015) -
Global gene expression profiling analysis reveals reduction of stemness after B-RAF inhibition in colorectal cancer cell lines
por: Boerries, Melanie, et al.
Publicado: (2015) -
BRaf(V600E) cooperates with Pten silencing to elicit metastatic melanoma
por: Dankort, David, et al.
Publicado: (2009) -
Loss of Phd2 cooperates with BRAF(V600E) to drive melanomagenesis
por: Liu, Shujing, et al.
Publicado: (2018) -
Acquired resistance to BRAF inhibition in BRAF(V600E) mutant gliomas
por: Yao, Tsun-Wen, et al.
Publicado: (2016)